← Back to Clinical Trials
Recruiting NCT07555873

NCT07555873 Osteopathic Manipulative Treatment vs Physiotherapy in Cervicocranial Dysfunction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07555873
Status Recruiting
Phase
Sponsor Burim Peli
Condition Cervicogenic Headache
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2026-05-01
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Participants in this group will receive osteopathic manipulative treatment (OMT) targeting cervicocrconventional physiotherapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2026-05-01 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to compare the effects of osteopathic manipulative treatment and standard physiotherapy in patients with cervicocranial dysfunction. The study will evaluate outcomes including dizziness, headache impact, neck disability, and psychological stress. Participants will be randomly assigned to one of two groups: osteopathic treatment or standard physiotherapy. The interventions will be applied over a defined treatment period, and outcomes will be measured before and after the intervention. The purpose of this study is to determine which approach is more effective in improving symptoms and functional outcomes in patients with cervicocranial dysfunction.

Eligibility Criteria

Inclusion Criteria: * Participants will be eligible for inclusion in the study if they meet the following criteria: * Age between 18 and 65 years. * Presence of cervicocranial symptoms for at least three months, indicating a chronic condition. * Neck pain with or without associated headache. * Dizziness associated with neck movement or cervical position. * Clinical findings consistent with cervicocranial dysfunction, based on clinical examination. * Ability to understand and complete standardized clinical questionnaires used in the study. * Willingness to participate in the study and provision of written informed consent. Exclusion Criteria: * Participants will be excluded from the study if they present with any of the following conditions: * Clinically confirmed vestibular disorders. * Central neurological disorders that may influence dizziness or balance. * Recent severe trauma to the cervical spine. * History of cervical spine surgery. * Systemic inflammatory diseases or serious spinal pathologies. * Presence of red flags related to the cervical spine identified during clinical screening. * Participation in concurrent intensive physiotherapy or rehabilitation treatment during the study period.

Contact & Investigator

Central Contact

Burim Peli, Phd cand.

✉ burimpeli@hotmail.com

📞 +38349600053

Frequently Asked Questions

Who can join the NCT07555873 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Cervicogenic Headache. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07555873 currently recruiting?

Yes, NCT07555873 is actively recruiting participants. Contact the research team at burimpeli@hotmail.com for enrollment information.

Where is the NCT07555873 trial being conducted?

This trial is being conducted at Pristina, Kosovo.

Who is sponsoring the NCT07555873 clinical trial?

NCT07555873 is sponsored by Burim Peli. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology